PMID: 9444987Jan 28, 1998Paper

DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector

Journal of Virology
Mangala J HariharanT A Banks

Abstract

Previously we reported the development of a plasmid DNA expression vector system derived from Sindbis virus (T. W. Dubensky, Jr., et al., J. Virol. 70:508-519, 1996). In vitro, such vectors exhibit high-level heterologous gene expression via self-amplifying cytoplasmic RNA replication. In the present study, we demonstrated the in vivo efficacy of the Sindbis virus-based pSIN vectors as DNA vaccines. A single intramuscular immunization of BALB/c mice with pSIN vectors expressing the glycoprotein B of herpes simplex virus type 1 induced a broad spectrum of immune responses, including virus-specific antibodies, cytotoxic T cells, and protection from lethal virus challenge in two different murine models. In addition, dosing studies demonstrated that the pSIN vectors were superior to a conventional plasmid DNA vector in the induction of all immune parameters tested. In general, 100- to 1,000-fold-lower doses of pSIN were needed to induce the same level of responsiveness as that achieved with the conventional plasmid DNA vector. In some instances, significant immune responses were induced with a single dose of pSIN as low as 10 ng/mouse. These results indicate the potential usefulness of alphavirus-based vectors for DNA immunization ...Continue Reading

References

Aug 1, 1991·AIDS Research and Human Retroviruses·J F WarnerD St Louis
Aug 1, 1995·Immunity·D M Pardoll, A M Beckerleg
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·X ZhouM Jondal
Oct 1, 1994·Current Opinion in Biotechnology·P Liljeström
Sep 1, 1994·Microbiological Reviews·J H Strauss, E G Strauss
Jan 1, 1994·Human Gene Therapy·M VitadelloS Schiaffino
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E F FynanH L Robinson
Sep 1, 1995·Human Gene Therapy·H HerweijerJ A Wolff
Nov 27, 1995·Annals of the New York Academy of Sciences·D A DriverD J Jolly
Apr 1, 1996·The Journal of Infectious Diseases·N BourneD Lew
Mar 1, 1996·The Journal of Infectious Diseases·J D KrieselB A Araneo
Jun 1, 1996·Journal of Virology·S LuH L Robinson
Jan 1, 1996·Viral Immunology·H C Ertl, Z Q Xiang
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·I FrolovC M Rice
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·C J WheelerS H Cheng
Oct 1, 1996·Current Opinion in Biotechnology·H V Huang
Dec 1, 1996·Current Opinion in Biotechnology·J B UlmerM A Liu
Feb 3, 1997·FEBS Letters·G GregoriadisJ B de Souza
Jan 1, 1997·Annual Review of Immunology·J J DonnellyM A Liu

❮ Previous
Next ❯

Citations

Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·J M PoloT W Dubensky
Dec 1, 2001·Expert Opinion on Biological Therapy·S Schlesinger
Dec 1, 2001·Expert Opinion on Biological Therapy·S K EoB T Rouse
Mar 22, 2002·Journal of Virology·Itaru AnrakuAlexander A Khromykh
Mar 26, 2003·Infection and Immunity·Kris Huygen
Feb 8, 2003·DNA and Cell Biology·Georgetta Cannon, Drew Weissman
Nov 22, 2005·Expert Opinion on Drug Delivery·H Oya AlparVincent W Bramwell
Oct 13, 2006·Human Gene Therapy·Margaret A LiuGunilla B Karlsson Hedestam
Mar 21, 2008·Expert Opinion on Biological Therapy·Chien-Fu HungT-C Wu
Mar 5, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jun-Han SuT-C Wu
Mar 8, 2012·Reviews in Medical Virology·Erin Chung, Jonathan Sen
Mar 23, 2012·Animal Health Research Reviews·Ryan L Vander VeenKurt I Kamrud
Sep 8, 2012·Cancer Gene Therapy·R SuzmeA Pellicer
Jun 18, 2014·Viruses·Kenneth Lundstrom
Jun 3, 2000·Annual Review of Immunology·S GurunathanR A Seder
Dec 24, 2002·Nature Medicine·Wolfgang W LeitnerNicholas P Restifo
Oct 13, 2000·American Journal of Respiratory and Critical Care Medicine·J J DonnellyJ B Ulmer
Jan 26, 2011·Virology Journal·Tanja I NäslundPeter Liljeström
Mar 20, 2020·Biomedicines·Altijana Hromic-Jahjefendic, Kenneth Lundstrom
Jun 13, 1998·Nature Biotechnology·J M Polo, T W Dubensky
May 19, 1998·Nature Medicine·M A Liu
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·E V AgapovC M Rice
Jul 8, 1999·Nature Medicine·H YingN P Restifo
Oct 8, 2003·Technology in Cancer Research & Treatment·Kenneth Lundstrom, Teni Boulikas
Nov 13, 2008·Expert Reviews in Molecular Medicine·Gregory J AtkinsBrian J Sheahan
Oct 2, 2014·Expert Review of Vaccines·Karl Ljungberg, Peter Liljeström
Dec 12, 2012·Journal of Virology·Svetlana AtashevaIlya Frolov
Aug 12, 2014·Journal of Fish Diseases·M L Ogas CastellsT V Poggio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anal Dysplasia

Anal dysplasia is a precancerous condition in which some cells within the anus transform into abnormal cells. Discover the latest research on anal dysplasia here.

Bowen's Disease

Bowen's disease is thought of as an easily-treatable early stage of skin cancer, characterized by red, scaly patches on the skin. Discover the latest research on Bowen's disease here.